Katherine Ember

From Oxford to Edinburgh to Montréal, Katherine has pioneered optical technologies that transform how we detect disease in real time. Her research has generated patent-pending diagnostic tools, $3.9M in funding, and a successful spin-off translating lab discoveries into real-world health solutions. With 40+ researchers mentored, 17 publications, 22 international conference talks, and multiple awards, she brings both scientific depth and visionary leadership to Aion’s biomarker mission.